35
Precision Neuroscience Corp raises $250M under Reg D
Company raise · Open-ended · Offering Indefinite · Sold $250M · NEW YORK, NY · filed 2026-09-28
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
| Eric M. Attias | Director |
| Craig Mermel | President and Chief Product Officer |
| Howard M. Morgan | Director |
| MIchael M. Kaswan | Chief Financial Officer |
| Benjamin Rapoport | President, Chief Science Officer |
| Ravi Mehta | Director |
| Jason Chen | Director |
| Michael Mager | Chief Executive Officer |
Signed by Michael Mager, Chief Executive Officer.
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.